Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
Deborah J. Wexler, MD, MSc, is Associate Professor of Medicine at Harvard Medical School, Boston, Massachusetts and Chief of the MGH Diabetes Unit. She received her medical degree from Yale University School of Medicine, New Haven, Connecticut and completed her internship, residency, and chief residency in internal medicine and fellowship in endocrinology at Massachusetts General Hospital.
Dr. Wexler’s research focuses on clinical effectiveness in type 2 diabetes. She has led multiple NIDDK- and PCORI- funded projects that seek to improve the health and well-being of people with diabetes. She served on the American Diabetes Association’s Professional Practice Committee (2014-2016) and was a co-author of the 2018-2019 ADA-EASD position statement on management of hyperglycemia in type 2 diabetes. Dr Wexler is on the Editorial Board of Diabetes Care, is a reviewer for multiple medical journals, and is an editor of NIDDK’s Diabetes in America.
Clinical Interests:
Treats:
Mass General Endocrinology: Diabetes Clinical Center
50 Staniford St.
Suite 340
Boston, MA 02114
Phone: 617-726-8722
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
Researchers from Mass General shed light on whether newly diagnosed diabetes in COVID-19 patients is truly new or merely previously undiagnosed
The study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug.
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
Researchers from Mass General shed light on whether newly diagnosed diabetes in COVID-19 patients is truly new or merely previously undiagnosed
The study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug.
Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.